Screener
Eli Lilly LLY Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Eli Lilly’s reported figures.
Based on the most recent quarter.
The source filing: Eli Lilly’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 11:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000059478-26-000045
FAQ
- What is Eli Lilly's debt-to-equity?
- Eli Lilly (LLY) reported debt-to-equity of 1.4× in Q1 2026.
- How has Eli Lilly's debt-to-equity changed year-over-year?
- Eli Lilly's debt-to-equity decreased by 43.1% year-over-year, from 2.4× to 1.4×.
- What is the long-term trend for Eli Lilly's debt-to-equity?
- Over 5 years (2020 to 2025), Eli Lilly's debt-to-equity has grown at a -12.0% compound annual growth rate (CAGR), from 3.1× to 1.6×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Eli Lilly's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude